McMullin David 4/A
4/A · Aldeyra Therapeutics, Inc. · Filed Mar 6, 2020
Insider Transaction Report
Form 4/AAmended
McMullin David
SVP Corp. Dev. & Strategy
Transactions
- Award
Common Stock
2020-03-02+247,480→ 255,183 total - Award
Employee Stock Option (Right to Buy)
2020-03-02+250,000→ 250,000 totalExercise: $3.78Exp: 2030-03-01→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
- [F2]Includes an additional 1,555 shares of common stock previously acquired under the Issuer's Employee Stock Purchase Plan.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2020.